期刊簡介 | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL BIOMECHANICS LetPub Score 5.6
50 ratings
Rate
Reputation 6.4 Influence 4.3 Speed 9.1 | |||||||||||||||||||||
期刊簡稱 | CLIN BIOMECH | |||||||||||||||||||||
ISSN | 0268-0033 | |||||||||||||||||||||
E-ISSN | 1879-1271 | |||||||||||||||||||||
h-index | 115 | |||||||||||||||||||||
CiteScore |
| |||||||||||||||||||||
自引率 (2023-2024) | 7.10%自引率趨勢 | |||||||||||||||||||||
掲載範囲 |
| |||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/clinical-biomechanics/ | |||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CLBI | |||||||||||||||||||||
開放訪問 | No | |||||||||||||||||||||
出版商 | Elsevier Ltd | |||||||||||||||||||||
主題領域 | 医学 | |||||||||||||||||||||
出版國/地區 | ENGLAND | |||||||||||||||||||||
發行頻率 | 月刊 | |||||||||||||||||||||
創刊年 | 1986 | |||||||||||||||||||||
每年文章數 | 191每年文章數趨勢 | |||||||||||||||||||||
黃金OA百分比 | 18.14% | |||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q3
| |||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | |||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0268-0033%5BISSN%5D | |||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) 來自Elsevier的數據: Average 12.3 Week(s) | |||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | |||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 5.6 Week(s) | |||||||||||||||||||||
參考鏈接 |
| |||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CLINICAL BIOMECHANICS] 的評論 | 撰寫評論 |
作者: Vikko 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-08 16:12:30 評論於 I don't know if the editors of this publication have contracted COVID-19 or not.(0) 讚! | Vikko |
作者: Vikko 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-08 16:11:10 評論於 Submitted for a month, still submitting to the journal.(0) 讚! | Vikko |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:10:49 評論於 The discussion section is the core part of a scientific paper, as it can reflect the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. The length of the discussion section varies depending on the article and the author, ranging from a few thousand words to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:47:03 評論於 What is IF?(0) 讚! | 八坂篷蔚 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 21:18:28 評論於 Does the lengthy discussion demonstrate the author's reflection on the topic? Does it leave a good impression on the manuscript reviewer?(0) 讚! | 破戒阳平 |
作者: yakuhi 領域: 工程技术 審稿時間: 3.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-14 11:54:30 評論於 Three months after the major revision, it has been half a month since the resubmission, but there has been no update or information. The response to inquiries is also slow. I'm not sure what the chances are of the revised submission being rejected.(0) 讚! | yakuhi |
作者: strongp 領域: 医学 審稿時間: 11.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-09-15 22:13:53 評論於 Need to recommend reviewers.(0) 讚! | strongp |
作者: MR Chang 領域: 生物学 審稿時間: 1.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-17 23:16:06 評論於 Do you need recommendations for reviewers?(0) 讚! | MR Chang |
作者: strongp 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2020-08-23 11:16:44 評論於 2019.9.22 submission; 2020.1.15 first major revision required; 2020.3.22 first minor major revision required; 2020.5.17 second minor revision required; 2020.7.8 third minor revision required; 2020.8.21 accepted. The editors and reviewers are good and very responsible, and the comments are also very good. (1) 讚! | strongp |
作者: 一吃就胖小彭彭 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-13 10:16:34 評論於 Review Speed: 12.0 | Submission Hit Rate: 50.0 Experience sharing: Submitted in October last year, received major revision in May this year, and accepted half a month after revision. The magazine has low efficiency, and only gives one chance for major revision when reviewing emails. Articles that are not urgent can give it a try(0) 讚! | 一吃就胖小彭彭 |
作者: 长安锐利 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-02-21 21:22:13 評論於 Review speed: 12.0 | Submission accuracy rate: 50.0 Experience sharing: The review speed is slow, but the accuracy rate is still acceptable. Suitable for articles that are not urgent(0) 讚! | 长安锐利 |
作者: 长安锐利 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-17 16:51:28 評論於 I submitted it in March of last year, but it wasn't reviewed until October. It feels very slow, haha(0) 讚! | 长安锐利 |
作者: 花拳翔宇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-01-12 17:02:51 評論於 Review Speed: 12.0 Experience Sharing: Submitted in June last year, still under review now, urged once but did not speed up, planning to withdraw after the New Year(0) 讚! | 花拳翔宇 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-01-14 22:26:31 評論於 The experience in BiologyValley SCI is rich, their attitude is super good, maybe I published in a good mood, but at least the articles I cooperated with them have been published. Getting back to the point, this journal is one of the top 2 journals in orthopedics, and last year it increased to 2 points, comparable to Spine. The review time is relatively long, the questions are sharp, but once you enter the revision stage, the success rate is not low(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us